Current problems in cardiologyHumansCardiovascular DiseasesObesityGlucagon-Like Peptide-1 Receptor AgonistsHypoglycemic Agents
GLP1-RAs: long-term use versus discontinuation events of an emerging therapy for obesity and cardiovascular diseases.
Elia Nunzio Maria Salerno, Isabella Fumarulo, Barbara Garramone, Marcello Vaccarella, Carolina Ierardi, Francesco Burzotta, Nadia Aspromonte
Published: 202610.1016/j.cpcardiol.2025.103213
Abstract
Obesity is a highly prevalent chronic disease strongly associated with cardiometabolic complications, including type 2 diabetes, hypertension, heart failure and other cardiovascular diseases. The growing understanding of these interrelationships has…
Preview only. Read the full abstract at the source